|
⚲
|
| Keyboard |
| Ospraie Management LLC
✚
|
|
|---|---|
| CRD # | 305479 |
| SEC # | 801-119728 |
| CIK # | 0001326533, 0001392203 |
| AUM | 1,259.7 M (2026-03-31) |
| Employees | 20 (50% Investors, 0% Brokers) |
| Phone | 212-602-5000 |
| Address | 411 Theodore Fremd Ave Rye, NY 10580 |
| Source | [IAPD] [EDGAR] [Website] [Twitter] [LinkedIn] |
| Total AUM ($B) |
|---|
| Type | Form D Funds | Date | Sold | AUM |
|---|---|---|---|---|
| Other | ORA Battle Swine LLC | 2025-03-28 | 27.2 M | |
| PE | Ospraie Real Assets Fund LP | [2024-03-28] | 1,248.2 M | 879.8 M |
| Offered $1,248,195,264 · Filed 2023-06-30 (D) · Exemption 506(b), 3(c), 3(c)(7) · Duration More than one year · Revenue Decline to Disclose | ||||
| VC | Ospraie AG Science LLC | [2019-10-02] | 237.1 M | 85.6 M |
| Filed 2025-09-05 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration More than one year · Revenue Decline to Disclose | ||||
| HF | Ospraie Equity Fund LP | [2012-03-29] | 77.5 M | 59.9 M |
| Filed 2012-08-15 (D/A) · Exemption 506, 3(c)(7) · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose | ||||
| HF | Ospraie Equity Fund Ltd | [2012-03-29] | 2.5 M | 6.5 M |
| Filed 2012-08-15 (D/A) · Exemption 506, 3(c)(7) · Minimum $100,000 · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose | ||||
| HF | Ospraie Equity Master Fund LP | 2012-03-29 | 78.1 M | |
| PE | Ospraie Special Opportunities LP | 2012-03-29 | 40.0 M | |
| PE | Ospraie Special Opportunities Master Alternative Holdings LLC | 2012-03-29 | 7.6 M | |
| PE | Ospraie Special Opportunities Master Holdings Ltd | 2012-03-29 | 96.5 M | |
| PE | Ospraie Special Opportunities Offshore Ltd | [2012-03-29] | 69.7 M | |
| View All | ||||
| AUM Breakdown | Accounts | AUM ($B) |
|---|---|---|
| By Client Type | ||
| (a) Individuals (other than high net worth individuals) | 0 | 0.0 |
| (b) Individuals (high net worth individuals) | 0 | 0.0 |
| (c) Banking or thrift institutions | 0 | 0.0 |
| (d) Investment companies | 0 | 0.0 |
| (e) Business development companies | 0 | 0.0 |
| (f) Pooled investment vehicles | 3 | 1.2 |
| (g) Pension and profit sharing plans | 0 | 0.0 |
| (h) Charitable organizations | 0 | 0.0 |
| (i) State or municipal government entities | 1 | 0.1 |
| (j) Other investment advisers | 0 | 0.0 |
| (k) Insurance companies | 0 | 0.0 |
| (l) Sovereign wealth funds and foreign official institutions | 0 | 0.0 |
| (m) Corporations or other businesses not listed above | 0 | 0.0 |
| (n) Other | 1 | 0.0 |
| Total | 5 | 1.3 |
| By Discretionary | ||
| Discretionary | 4 | 1.3 |
| Non-Discretionary | 1 | 0.0 |
| Total | 5 | 1.3 |
| By Non-United States Persons | ||
| Non-United States Persons | 0.0 | |
| United States Persons | 1.3 | |
| Total | 5 | 1.3 |
| Form D Directors | Role | # Filings | # Firms | 2011 - 2026 |
|---|---|---|---|---|
| Gary Linford | Director | 176 | 42 | |
| John Lewis | Director | 289 | 39 | |
| Dwight Anderson | Executive Officer | 7 | 2 | |
| Ospraie Management LLC | Promoter | 6 | 2 | |
| Ospraie Group II LLC | Executive Officer | 3 | 2 | |
| Nathan Ebeling | Promoter | 2 | 2 | |
| Ospraie Real Assets GP LLC | Executive Officer | 1 | 1 | |
| Oas MM LLC | Executive Officer | 1 | 1 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 13F-HR | [0001326533] | |
| 3 | [0001326533] | |
| 4 | [0001326533] | |
| 3 | [0001392203] | |
| 4 | [0001392203] |
| Firm Profile (Form ADV) | |
|---|---|
| Clients | 6 |
| Serves | Institutional |
| Fund Types | Hedge Fund, Private Equity |
| LEI | 549300BVQ8NJ3V9UIN21 |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Marrone Bio Innovations Inc MBII
Common Stock, $0.00001 par value
|
2022-07-12 | Tender | 70,836,258 | ||
|
Marrone Bio Innovations Inc MBII
Warrant · derivative
|
2021-12-15 | Option exercise | 3,553,583 | ||
|
Marrone Bio Innovations Inc MBII
Common Stock, $0.00001 par value
|
2021-12-15 | Option exercise | 3,553,583 | $0.75 | 2,665,187 |
|
Marrone Bio Innovations Inc MBII
Warrant · derivative
|
2021-03-15 | Option exercise | 4,264,299 | ||
|
Marrone Bio Innovations Inc MBII
Common Stock, $0.00001 par value
|
2021-03-15 | Option exercise | 4,264,299 | $0.75 | 3,198,224 |
|
Marrone Bio Innovations Inc MBII
Common Stock, $0.00001 par value
|
2020-12-15 | Option exercise | 9,476,221 | $0.75 | 7,107,166 |
|
Marrone Bio Innovations Inc MBII
Warrant · derivative
|
2020-12-15 | Option exercise | 9,476,221 | ||
|
Marrone Bio Innovations Inc MBII
Warrant · derivative
|
2020-09-15 | Option exercise | 1,974,213 | ||
|
Marrone Bio Innovations Inc MBII
Common Stock, $0.00001 par value
|
2020-09-15 | Option exercise | 1,974,213 | $0.75 | 1,480,660 |
|
Marrone Bio Innovations Inc MBII
Warrant · derivative
|
2020-05-01 | Option exercise | 2,467,766 | ||
|
Marrone Bio Innovations Inc MBII
Common Stock, $0.00001 par value
|
2020-05-01 | Option exercise | 2,467,766 | $0.75 | 1,850,824 |
|
Marrone Bio Innovations Inc MBII
Warrant · derivative
|
2020-04-29 | Grant | 2,467,766 | ||
|
Marrone Bio Innovations Inc MBII
Warrant · derivative
|
2020-04-29 | Disposed to issuer | 5,027,325 | ||
|
Marrone Bio Innovations Inc MBII
Warrant · derivative
|
2020-04-29 | Disposed to issuer | 12,233,158 | ||
|
Marrone Bio Innovations Inc MBII
Warrant · derivative
|
2020-04-29 | Disposed to issuer | 8,378,871 | ||
|
Marrone Bio Innovations Inc MBII
Warrant · derivative
|
2020-04-29 | Disposed to issuer | 3,351,542 | ||
|
Marrone Bio Innovations Inc MBII
Warrant · derivative
|
2020-04-29 | Grant | 1,974,213 | ||
|
Marrone Bio Innovations Inc MBII
Warrant · derivative
|
2020-04-29 | Grant | 3,553,583 | ||
|
Marrone Bio Innovations Inc MBII
Warrant · derivative
|
2020-04-29 | Grant | 4,264,299 | ||
|
Marrone Bio Innovations Inc MBII
Warrant · derivative
|
2020-04-29 | Grant | 9,476,221 | ||
| showing 20 of 33 most recent transactions | |||||
| Comparable Firms | State | AUM |
|---|---|---|
|
FCO Advisors LP
✚
|
NY | 1,339.3 M |
|
Chilton Investment Company Inc
✚
|
CT | 1,323.2 M |
|
Framework Ventures Management LLC
✚
|
CA | 1,280.9 M |
|
PFM Health Sciences LP
✚
|
CA | 1,266.8 M |
|
WEBS Creek Capital Management LP
✚
|
TX | 1,254.4 M |
|
Seven Grand Managers LLC
✚
|
NY | 1,235.3 M |
|
Wynkoop LLC
✚
|
CO | 1,217.3 M |
|
Hudson Cove Capital Management LLC
✚
|
NJ | 1,213.5 M |
|
Arlon Advisor LLC
✚
|
NY | 1,176.7 M |
|
Octagon Capital Advisors LP
✚
|
NY | 1,175.3 M |